ID: ALA4746543

Max Phase: Preclinical

Molecular Formula: C46H64N10O10

Molecular Weight: 917.08

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)NCCOCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12

Standard InChI:  InChI=1S/C46H64N10O10/c1-31(2)34-14-17-55-42(34)43(49-30-50-55)51-32-6-8-33(9-7-32)53-18-20-54(21-19-53)40(59)13-12-38(57)48-16-23-64-25-27-66-29-28-65-26-24-63-22-15-47-36-5-3-4-35-41(36)46(62)56(45(35)61)37-10-11-39(58)52-44(37)60/h3-5,14,17,30-33,37,47H,6-13,15-16,18-29H2,1-2H3,(H,48,57)(H,49,50,51)(H,52,58,60)/t32-,33+,37?

Standard InChI Key:  ZWNQTQJUJKYBPF-MBSVEICTSA-N

Associated Targets(Human)

Cereblon/IRAK3 34 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Interleukin-1 receptor-associated kinase 3 577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Interleukin-1 receptor-associated kinase 4 5917 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 917.08Molecular Weight (Monoisotopic): 916.4807AlogP: 2.20#Rotatable Bonds: 24
Polar Surface Area: 227.37Molecular Species: NEUTRALHBA: 16HBD: 4
#RO5 Violations: 2HBA (Lipinski): 20HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 8.02CX LogP: 1.33CX LogD: 0.62
Aromatic Rings: 3Heavy Atoms: 66QED Weighted: 0.07Np Likeness Score: -0.97

References

1. Degorce SL,Tavana O,Banks E,Crafter C,Gingipalli L,Kouvchinov D,Mao Y,Pachl F,Solanki A,Valge-Archer V,Yang B,Edmondson SD.  (2020)  Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 Pseudokinase.,  63  (18): [PMID:32803978] [10.1021/acs.jmedchem.0c01125]

Source